clinical trial · NCT04002661
Hypoactive Sexual Desire Disorder in Males
Mohit Khera·phase2·terminated·n = 8
Low LibidoFlibanserinPlacebo
brief summary
The purpose of this study is to determine if the study drug will increase sexual desire in men with HSDD. Half of the participants will take ADDYI while the other half will receive a placebo (a look-alike pill with no medicine).
started
May 8, 2020
primary completion
Oct 31, 2025
completion
Jan 23, 2026
last updated
Jan 26, 2026
detailed description
This pilot randomized placebo controlled study will include 60 men (30 treatment and 30 placebo). ARM 1 will take flibanserin 100mg orally every night and ARM 2 will take a placebo orally every night.
There will be four study visits and the study duration is approximately 4 months. Participants will have physicals at each visit. Blood draws for tests will be done at 3 visits and up to 4 questionnaires will completed at each visit. Study drug will randomized.
official title
Hypoactive Sexual Desire Disorder in Males (10-18-40-13)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol